BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17130255)

  • 1. Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies.
    Gallego-Delgado J; Lazaro A; Osende JI; Esteban V; Barderas MG; Gomez-Guerrero C; Vega R; Vivanco F; Egido J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S159-64. PubMed ID: 17130255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies.
    Gallego-Delgado J; Connolly SB; Lázaro A; Sadlier D; Kieran NE; Sugrue DD; Doran P; Brady HR; Osende J; Egido J
    Hypertens Res; 2009 May; 32(5):347-57. PubMed ID: 19325563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy.
    Gallego-Delgado J; Lazaro A; Osende JI; Barderas MG; Duran MC; Vivanco F; Egido J
    J Proteome Res; 2006 Feb; 5(2):404-13. PubMed ID: 16457607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I.
    Donohue TJ; Dworkin LD; Ma J; Lango MN; Catanese VM
    J Investig Med; 1997 Dec; 45(9):584-91. PubMed ID: 9444886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial gene expression associated with genetic cardiac hypertrophy in the absence of hypertension.
    Dwyer JP; Ritchie ME; Smyth GK; Harrap SB; Delbridge L; Domenighetti AA; Di Nicolantonio R
    Hypertens Res; 2008 May; 31(5):941-55. PubMed ID: 18712050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of antihypertensive drugs in the heart of animal models: a proteomic approach.
    Lázaro A; Gállego-Delgado J; Osende JI; Egido J; Vivanco F
    Methods Mol Biol; 2007; 357():45-58. PubMed ID: 17172677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tong-xin-luo capsule inhibits left ventricular remodeling in spontaneously hypertensive rats by enhancing PPAR-gamma expression and suppressing NF-kappaB activity.
    Bu PL; Zhao XQ; Wang LL; Zhao YX; Li CB; Zhang Y
    Chin Med J (Engl); 2008 Jan; 121(2):147-54. PubMed ID: 18272042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
    Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
    Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polyphenol-containing azuki bean (Vigna angularis) extract on blood pressure elevation and macrophage infiltration in the heart and kidney of spontaneously hypertensive rats.
    Sato S; Mukai Y; Yamate J; Kato J; Kurasaki M; Hatai A; Sagai M
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):43-9. PubMed ID: 18047626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional alterations in the left ventricle of three hypertensive rat models.
    Cerutti C; Kurdi M; Bricca G; Hodroj W; Paultre C; Randon J; Gustin MP
    Physiol Genomics; 2006 Nov; 27(3):295-308. PubMed ID: 16882881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor.
    Bian YL; Qi YX; Yan ZQ; Long DK; Shen BR; Jiang ZL
    Eur J Cell Biol; 2008 Feb; 87(2):101-10. PubMed ID: 17963997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo protein synthetic rates of atrial, ventricular, and pulmonary tissue proteins in aortic constriction, goldblatt, and bromoethylamine models of hypertension.
    Siddiq T; Patel VB; Sherwood R; Richardson PJ; Preedy VR
    Exp Mol Pathol; 2001 Feb; 70(1):19-30. PubMed ID: 11170787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirt1 hyperexpression in SHR heart related to left ventricular hypertrophy.
    Li L; Zhao L; Yi-Ming W; Yu YS; Xia CY; Duan JL; Su DF
    Can J Physiol Pharmacol; 2009 Jan; 87(1):56-62. PubMed ID: 19142216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between increased left ventricular mass and "normal" QRS voltage is associated with decreased connexin 43 expression in early stage of left ventricular hypertrophy in spontaneously hypertensive rats.
    Bacharova L; Plandorova J; Klimas J; Krenek P; Kyselovic J
    J Electrocardiol; 2008; 41(6):730-4. PubMed ID: 18358486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
    Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
    Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged QT interval is associated with blood pressure rather than left ventricular mass in spontaneously hypertensive rats.
    Klimas J; Stankovicova T; Kyselovic J; Bacharova L
    Clin Exp Hypertens; 2008 Oct; 30(7):475-85. PubMed ID: 18855252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of left ventricular diastolic dysfunction hearts in renovascular hypertensive rats.
    Junhong W; Jing Y; Jizheng M; Shushu Z; Xiangjian C; Hengfang W; Di Y; Jinan Z
    Int J Cardiol; 2008 Jul; 127(2):198-207. PubMed ID: 17659790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
    Allen AR; Kelso EJ; Bell D; Zhao Y; Dickson P; McDermott BJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1286-96. PubMed ID: 16973886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term organ protection by doxazosin and/or quinapril as antihypertensive therapy.
    Gallego-Delgado J; Lazaro A; Gomez-Garre D; Osende JI; Gonzalez-Rubio ML; Herraiz M; Manzarbeitia F; Fortes J; Fernandez-Cruz A; Egido J
    J Nephrol; 2006; 19(5):588-98. PubMed ID: 17136686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.